Bruker Corporation  

(Public, NASDAQ:BRKR)   Watch this stock  
Find more results for Anthony Emmerich
17.83
-0.55 (-2.99%)
Sep 1 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 17.73 - 18.18
52 week 17.26 - 22.32
Open 18.06
Vol / Avg. 589,735.00/729,901.00
Mkt cap 3.09B
P/E 50.40
Div/yield     -
EPS 0.35
Shares 168.15M
Beta 1.08
Inst. own 70%
Nov 11, 2015
Bruker Corp at Credit Suisse Healthcare Conference Add to calendar
Nov 4, 2015
Bruker Corp at Citi Global Healthcare Conference Add to calendar
Nov 3, 2015
Q3 2015 Bruker Corp Earnings Call - 4:45PM EST - Add to calendar
Nov 3, 2015
Q3 2015 Bruker Corp Earnings Release - 4:00PM EST - Add to calendar
Sep 8, 2015
Bruker Corp at Morgan Stanley Healthcare Conference Add to calendar
Aug 5, 2015
Q2 2015 Bruker Corp Earnings Call
Aug 5, 2015
Q2 2015 Bruker Corp Earnings Release
Jun 17, 2015
Bruker Corp at Wells Fargo Healthcare Conference
Jun 9, 2015
Bruker Corp at William Blair Annual Growth Stock Conference
Jun 9, 2015
Bruker Corp at Goldman Sachs Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '15) 2014
Net profit margin 5.83% 3.29%
Operating margin 7.98% 5.83%
EBITD margin - 10.76%
Return on average assets 5.16% 3.09%
Return on average equity 11.90% 7.03%
Employees 6,100 -
CDP Score - -

Address

40 MANNING RD
BILLERICA, MA 01821
United States - Map
+1-978-6633660 (Phone)
+1-978-6635585 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Bruker Corporation is a designer and manufacturer of life science and materials research systems and associated products that address the needs of a range of customers in life science research, pharmaceuticals, applied markets, nanotechnology, cell biology, clinical research, microbiology and in-vitro diagnostics. The Company operates through two segments: Bruker Scientific Instruments (BSI) and Bruker Energy & Supercon Technologies (BEST). BSI is organized into three operating segments: the Bruker BioSpin Group, the Bruker CALID Group and the Bruker Nano Group. BEST designs, manufactures and distributes superconducting materials. The company maintains technical and manufacturing centers in Europe and North America, and it has sales offices located throughout the world.

Officers and directors

Frank H. Laukien Ph.D. Chairman of the Board, President, Chief Executive Officer
Age: 55
Bio & Compensation  - Reuters
Anthony L Mattacchione Interim Chief Financial Officer, Senior Vice President - Finance & Accounting
Age: 51
Bio & Compensation  - Reuters
Thomas W. Bachmann President of Bruker BioSpin Group
Age: 56
Bio & Compensation  - Reuters
Bernd Gewiese Ph.D. Co-President of Bruker BioSpin Corporation
Age: 55
Bio & Compensation  - Reuters
Werner E. Maas Ph.D. Co-President of Bruker BioSpin Corporation
Age: 49
Bio & Compensation  - Reuters
Mark R. Munch Ph.D. President, Bruker Nano Surfaces Division and Bruker MAT Group
Age: 53
Bio & Compensation  - Reuters
Juergen Srega President of Bruker CALID Group
Age: 60
Bio & Compensation  - Reuters
Michael Gunnar Knell Vice President - Finance, Chief Accounting Officer
Age: 38
Bio & Compensation  - Reuters
William A. Linton Lead Independent Director
Age: 67
Bio & Compensation  - Reuters
Joerg C. Laukien Director
Age: 61
Bio & Compensation  - Reuters